The antiviral drug remdesivir has been used heavily by doctors combatting the novel coronavirus, and is a major part of a WHO study that is unprecedented in its scope and speed. Yet on Monday, the Trump administration’s FDA granted its maker, Gilead, new authority to control access to the drug by
Orphan rescue
Orphan rescue
Orphan rescue
The antiviral drug remdesivir has been used heavily by doctors combatting the novel coronavirus, and is a major part of a WHO study that is unprecedented in its scope and speed. Yet on Monday, the Trump administration’s FDA granted its maker, Gilead, new authority to control access to the drug by